Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

WASHINGTON—U.S. Senator Mike Braun questioned Novo Nordisk CEO, Lars Fruergaard Jørgensen, at the Senate Health, Education, ...

Sanders found unlikely common ground with pro-Trump Elon Musk, citing the tech mogul as “right” on “solving obesity” in a ...

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help ...

People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to a study ...

From a moral perspective, does it bother you knowing that keeping the price of Ozempic and Wegovy so high in the United ...

Novo Nordisk said it’s open to discussions with PBMs based on their commitments that a lower semgalutide list price would not ...

"Yankees Are Aaron Judge's Team": Juan Soto's Disinterest In Playing Second Fiddle to Hamper Pinstripes' Offseason Chances ...

Novo Nordisk has a price fix solution for uninsured patients with diabetes, but not for HSA holders or people with normal ...

U.S. Sen. Bernie Sanders said major PBMs have agreed not to limit coverage of Ozempic and Wegovy if Novo lowers its prices.

Novo Nordisk's top executive faced a Senate grilling on Tuesday over the high prices of the company's weight loss drug Wegovy and diabetes treatment Ozempic, as demand for both injections soars in the ...

Visa's stock closed more than 5% lower for the day. Senators grilled Novo Nordisk CEO Lars Fruergaard Jørgensen at a hearing on Tuesday over the high prices of the company's blockbuster injections.